[1]Patent:WO2012/33525,2012,A2.Locationinpatent:Page/Pagecolumn115;116
Title: Huang Y, et al. Discovery of highly potent p53-MDM2 antagonists and structural basis for anti-acute myeloid leukemia activities. ACS Chem Biol. 2014 Mar 21;9(3):802-11.
1225037-39-7 | 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine | AA009CGU | MFCD28902193
121494-09-5 | TCV-309 (chloride) | AA009CL0 | MFCD30343857
130340-04-4 | Trans-2-fluorocyclopropanecarboxylic acid | AA009D10 | MFCD11499062
1312440-85-9 | 4-Boc-1-[(3-bromobenzene)sulfonyl]homopiperazine | AA009DC5 | MFCD19288880
1220030-34-1 | 2-methyl-3,5,6,7-tetrahydro-4H-pyrrolo[3,4-d]pyrimidin-4-one | AA009DQT | MFCD17078850
1215295-98-9 | 3-Ethylisoxazole-5-carbonitrile | AA009DUN | MFCD14702888
14158-75-9 | 4'-Chloro CloMiphene Citrate (E/Z Mixture) | AA009E0G | MFCD31561747
1329611-24-6 | (S)-(-)-VerapaMil-d6 Hydrochloride | AA009E6O
135729-76-9 | (S)-2-((1S,3R,4S)-Quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride | AA009EEG | MFCD29058561
1286129-04-1 | Fenoterol-d6 Hydrobromide | AA009ENV